A dynamic view to the modulation of phosphorylation and O-GlcNAcylation by inhibition of O-GlcNAcase
Related Experiment Video
Updated: May 12, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
1EnVivo Pharmaceuticals, 500 Arsenal Street, Watertown, MA 02472, USA. ctang@envivopharma.com
Abstract:
Protein phosphorylation and O-GlcNAcylation are reciprocally regulated. As hyperphosphorylation is implicated in tau pathology, approaches have been exploited to reduce the magnitude of tau phosphorylation by increasing the level of tau O-GlcNAcylation. With mathematic models constructed to describe different kinetic scenarios, we analyzed the temporal change of an O-GlcNAcylated protein in contrast to that of the phosphorylated form upon inhibition of O-GlcNAcase (OGA). The analyses indicate that when degradation of the modified protein is negligible relative to the naked one, the magnitude of O-GlcNAcylated protein increase is proportional to the level of inhibition, while the extent of phosphorylated protein decline varies due to other factors. Furthermore, the increase of O-GlcNAcylated protein parallels with the decrease of phosphorylated form upon acute or short-term inhibition of OGA, as observed in many in vitro and short term in vivo studies. However, phosphorylated protein is predicted to return to its initial level while O-GlcNAcylated protein to achieve a higher steady level under sustained inhibition. This simulated result is in line with a recent report on long-term inhibition of OGA in transgenic mice. Noticeably, inhibition withdrawal is anticipated to cause a transient rise of phosphorylated protein. If degradation of modified proteins proceeds in addition to the naked one, the characteristic temporal profiles of each form in response to OGA inhibition would depend on the relative importance of individual degradation pathways. The models described herein may serve as a useful investigational tool that will provide insight into pharmacological intervention for tauopathies in particular and for reciprocally modulated reactions in general.
Insights
Mathematical models show that inhibiting O-GlcNAcase (OGA) increases O-GlcNAcylated tau protein and decreases phosphorylated tau. Sustained inhibition leads to higher O-GlcNAcylated levels and a return of phosphorylated tau to baseline, offering insights into tauopathies.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Protein phosphorylation and O-GlcNAcylation are reciprocally regulated post-translational modifications.
- Hyperphosphorylation of tau protein is a key factor in tauopathies, such as Alzheimer's disease.
Purpose of the Study:
- To analyze the temporal dynamics of O-GlcNAcylated and phosphorylated tau protein levels upon O-GlcNAcase (OGA) inhibition using mathematical models.
- To explore the impact of different degradation rates on these dynamics.
Main Methods:
- Development and analysis of mathematical models simulating protein modification kinetics.
- Comparison of simulated temporal changes in O-GlcNAcylated and phosphorylated protein levels under varying OGA inhibition and degradation scenarios.
Main Results:
- Under negligible degradation, O-GlcNAcylated protein increase is proportional to OGA inhibition, while phosphorylated protein decline varies.
- Acute OGA inhibition shows parallel increases in O-GlcNAcylated and decreases in phosphorylated tau.
- Sustained OGA inhibition predicts a return of phosphorylated tau to baseline and a higher steady-state level of O-GlcNAcylated tau.
Conclusions:
- Mathematical modeling provides insights into the complex interplay between tau phosphorylation and O-GlcNAcylation.
- These models can inform pharmacological interventions for tauopathies by predicting outcomes of OGA inhibition.
- The findings highlight the potential of modulating O-GlcNAcylation as a therapeutic strategy for neurodegenerative diseases involving tau pathology.
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
cAMP-dependent Protein Kinase Pathways
GTPases and their Regulation
Large G-proteins, also known...
